Minicircle is a method development company that has developed and seeks to commercialize the world’s first reversible human genetic enhancement platform, using highly expressive DNA plasmids to add genes to the human body without altering your pre-existing genome. Our reversible plasmid platform is completely non-inflammatory (unlike AAV) and non-heritable. It is designed as a universal gene therapy protocol. Minicircle makes gene therapy fast, safe, and easy to use.

Gene therapy promises unlimited health, independence from disease, and allows us to reimagine the future of our identity.